Joe Pariseau

Joe Pariseau

Company: C4 Therapeutics

Job title: Director, Clinical Development Sciences


Driving Progress for an Oral BRD9 Bifunctional Degrader 10:00 am

Identifying potent, selective, and orally bioavailable BiDAC™ degrader of BRD9 Showcasing a world-class degrader platform demonstrates effective degradation of previously undruggable target Presenting initial clinical data for dose finding escalation cohortsRead more

day: Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.